Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03491176 · ClinicalTrials.gov registry record

Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer

A clinical trial of Head and Neck Cancer and Healthy Subject, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
100
Enrollment target
1
Study location

NCT03491176 is a study of Head and Neck Cancer and Healthy Subject that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03491176, a study of Head and Neck Cancer and Healthy Subject, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to find out if using additional MRIs and biomarker testing can help researchers learn to predict how the tumor may change during radiation therapy. Biomarkers are found in the blood/tissue and may be related to participant's reaction to treatment. Biomarker testing in the study may include genetic biomarkers. This is an investigational study. MRIs on this study are performed using FDA-approved and commercially available methods. Having added scans and blood tests is investigational. Up to 100 participants will be enrolled in this study (up to 80 patients and up to 20 healthy volunteers in another part of the study). All will take part at MD Anderson.

Conditions Studied

Head and Neck Cancer Healthy Subject Cutaneous Squamous Cell Carcinoma of the Head and Neck

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Quality-of-Life Assessment
  • PROCEDURE Magnetic Resonance Imaging
  • OTHER Questionnaire Administration

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2017-05-18
Est. Completion 2027-10-31

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03491176

The ClinicalTrials.gov registry entry for NCT03491176 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (62% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.

NCT03491176 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03491176 about?

NCT03491176 is a clinical study titled "Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer". The goal of this research study is to find out if using additional MRIs and biomarker testing can help researchers learn to predict how the tumor may change during radiation therapy. Biomarkers are found in the blood/tissue and may be related to participant's reaction to treatment. Biomarker testin...

What is the current status of trial NCT03491176?

This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2017-05-18. Estimated completion is 2027-10-31.

What conditions does trial NCT03491176 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Healthy Subject, Cutaneous Squamous Cell Carcinoma of the Head and Neck.

What interventions are being tested in trial NCT03491176?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Quality-of-Life Assessment (OTHER), Magnetic Resonance Imaging (PROCEDURE), Questionnaire Administration (OTHER).

Who is sponsoring clinical trial NCT03491176?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03491176 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Healthy Subject

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.